Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Cancer Related Cognitive Decline × Breast × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2758 Triple Negative Breast Neoplasms 445 Ovarian Neoplasms 192 Carcinoma, Non-Small-Cell Lung 167 Colorectal Neoplasms 166 Prostatic Neoplasms 162 Neoplasms 159 Lung Neoplasms 146 Neoplasm Metastasis 142 Melanoma 102 Pancreatic Neoplasms 101 Stomach Neoplasms 100 Endometrial Neoplasms 99 Uterine Cervical Neoplasms 79 Squamous Cell Carcinoma of Head and Neck 76 Colonic Neoplasms 73 Head and Neck Neoplasms 70 Carcinoma, Intraductal, Noninfiltrating 64 Urinary Bladder Neoplasms 60 Sarcoma 57 Motor Activity 54 Breast Carcinoma In Situ 52 Esophageal Neoplasms 51 Carcinoma, Renal Cell 50 Brain Neoplasms 49 Lymphedema 39 Breast Cancer Female 37 HER2-positive Breast Cancer 34 Anatomic Stage I Breast Cancer AJCC v8 34 Lymphoma 32

Interventions

pertuzumab 1 azeliragon 1 Trastuzumab 1 Docetaxel 1 Cyclophosphamide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05256745 2025-12-24

RAGE

Georgetown University

Phase 1/2 Recruiting

Cancer Related Cognitive Decline

Data powered by HemOnc (CC BY 4.0) Colophon ⚡